INTRODUCTION
Controversy exists regarding type 2 diabetes (T2D) remission rates after bariatric surgery (BS) due to heterogeneity in its definition and patients' baseline features. The aim of this study is to evaluate T2D remission using recent consensus criteria, according to preoperative characteristics and insulin use.
PATIENTS AND METHODS
Retrospective study from a cohort of 657 BS performed in a single center, between the years 2006-2011, of which 141 (57.4% women) had pharmacologically-treated T2D. Evaluation of anthropometric, clinical and glucose metabolism parameters before surgery and at one-year follow-up.
Definition of T2D remission according to Buse et al: HbA1c <6% and fasting glucose (FG) <100 mg/dl in the absence of pharmacologic treatment. Analysis of diabetes remission according to previous treatment and other preoperative characteristics.
RESULTS

CONCLUSIONS
Buse criteria reveal lower T2D remission rates after BS than previously reported. Prior insulin use is a main setback for remission. Longer diabetes duration, lower %WL, %EWL and baseline C-peptide, higher age and female sex were associated to non-remission. Table 2 . Crude odds ratios (OR) and 95% confidence intervals (CI) of preoperative characteristics for prediction of T2D remission. Values show mean ± SD or number of patients and percentages (%). "Preop" = preoperative; "12m" = 12-month; "BMI" = body mass index; "FG" = fasting glucose; "HbA1c" = glycosylated hemoglobin; "%WL" = percentage body weight loss at 12 months; "%EWL" = percentage excess body weight loss at 12 months. p-values are shown for Chisquare test (categorical values) and analysis of variance (continuous variables).
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